How has been the historical performance of Vijaya Diagnost.?

Jul 21 2025 10:45 PM IST
share
Share Via
Vijaya Diagnost has shown consistent growth in net sales and profitability, with net sales increasing from 376.75 Cr in Mar'21 to 681.39 Cr in Mar'25, and net profit rising from 84.48 Cr to 143.08 Cr in the same period, reflecting strong operational efficiency. Total assets also grew significantly, from 300.64 Cr in Mar'19 to 979.83 Cr in Mar'24.
Answer:
The historical performance of Vijaya Diagnost shows a consistent growth trend in net sales and profitability over the years.

Breakdown:
Vijaya Diagnost has demonstrated significant growth in net sales, increasing from 376.75 Cr in Mar'21 to 681.39 Cr in Mar'25. The total operating income followed a similar trajectory, reaching 681.39 Cr in Mar'25, up from 459.22 Cr in Mar'23. The company's total expenditure has also risen, from 210.77 Cr in Mar'21 to 408.17 Cr in Mar'25, primarily driven by increases in raw material costs and employee expenses. Operating profit (PBDIT) has shown an upward trend, climbing from 177.83 Cr in Mar'21 to 291.54 Cr in Mar'25, reflecting a healthy operating profit margin of 40.1% in the latest fiscal year. Profit before tax has increased from 112.12 Cr in Mar'21 to 193.16 Cr in Mar'25, while profit after tax rose from 85.13 Cr to 143.79 Cr over the same period. The company's net profit also improved, reaching 143.08 Cr in Mar'25, compared to 84.48 Cr in Mar'21. On the balance sheet, total assets grew from 300.64 Cr in Mar'19 to 979.83 Cr in Mar'24, with total liabilities increasing correspondingly. Cash flow from operating activities has been positive, showing a rise from 90.00 Cr in Mar'19 to 183.00 Cr in Mar'24, despite cash flow from investing activities remaining negative. Overall, Vijaya Diagnost's financial performance reflects robust growth and operational efficiency over the years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News